The viabilities of B16 cells and NIH3T3 cells in response to MEL-A treatments.

Abstract

<p>(a), B16 cells treated with increasing doses of MEL-A had obvious changes. (b), the viability of the normal NIH3T3 cells treated by 15.0 μg/mL MEL-A for 72 h. (c, d, e, f) refers to the photographs of untreated B16 cells, and cells treated with MEL-A for 24 h, 48 h and 72 h. (g, h, m, n) refers to the photographs of untreated NIH3T3 cells and cells treated with MEL-A for 24 h, 48 h, and 72 h, respectively.</p